Literature DB >> 36018489

Interventional Magnetic Resonance Imaging Suite (IMRIS): How to build and how to use.

Matteo Stefanini1, Giovanni Simonetti2.   

Abstract

Over the last ten years, the number of minimally invasive interventional procedures has been increasing steadily. Magnetic resonance imaging (MRI) is still far less frequently used for image-guided percutaneous procedures or as an intervention method than computed tomography (CT) and ultrasound (US). However, MRI has many advantages, such as lack of ionizing radiation, real-time MR-fluoroscopy placement high resolution, no bone and gas artifacts, the ability to display lesions that are difficult to observe on CT and US visualization of blood vessels without a contrast agent, free selection of imaging planes and in the case of procedures such as thermos or cryoablation it is possible to make an intraprocedural assessment of the process without the application of a contrasting agent (Marini et al. in Diagn Interv Imaging 102: 531-538, 2021; Li et al. in BMC Cancer 21: 366, 2021; Barkhausen et al. in Rofo 189: 611, 2017). Furthermore, in addition to its use in Interventional Radiology, MRI is also becoming a reality in cardiology thanks to the possibility of overcoming all the limits related to the fusion technology used up to now in cardiac ablations (Chubb et al. Arrhythm Electrophysiol Rev 6: 85, 2017). Some suites have been built in Northern Europe and in the United States, but based only on personal experience and industry indication. In our hospital, we have built a new Interventional Magnetic Resonance Imaging Suite (IMRIS), the first in Southern Europe and we have defined what the necessary requirements and equipment were for the safety of the patient and the operator.
© 2022. Italian Society of Medical Radiology.

Entities:  

Keywords:  Cardiac ablation; Crioablation; Interventional magnetic resonance; Magneti resonance

Year:  2022        PMID: 36018489     DOI: 10.1007/s11547-022-01537-x

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   6.313


  6 in total

1.  Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.

Authors:  Pierre De Marini; Roberto Luigi Cazzato; Julien Garnon; Danoob Dalili; Ian Leonard-Lorant; Loïc Leclerc; Pierre-Alexis Autrusseau; Pierre Auloge; Julia Weiss; Thibault Tricard; Hervé Lang; Afshin Gangi
Journal:  Diagn Interv Imaging       Date:  2021-04-27       Impact factor: 4.026

2.  Cardiac Electrophysiology Under MRI Guidance: an Emerging Technology.

Authors:  Henry Chubb; Steven E Williams; John Whitaker; James L Harrison; Reza Razavi; Mark O'Neill
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 3.  White Paper: Interventional MRI: Current Status and Potential for Development Considering Economic Perspectives, Part 1: General Application.

Authors:  Jörg Barkhausen; Thomas Kahn; Gabriele A Krombach; Christiane K Kuhl; Joachim Lotz; David Maintz; Jens Ricke; Stefan O Schönberg; Thomas J Vogl; Frank K Wacker
Journal:  Rofo       Date:  2017-06-26

Review 4.  Endomyocardial biopsy in the clinical context: current indications and challenging scenarios.

Authors:  Aldostefano Porcari; Chiara Baggio; Enrico Fabris; Marco Merlo; Rossana Bussani; Andrea Perkan; Gianfranco Sinagra
Journal:  Heart Fail Rev       Date:  2022-05-14       Impact factor: 4.654

Review 5.  Myocardial fibrosis: morphologic patterns and role of imaging in diagnosis and prognostication.

Authors:  Carla Giordano; Marco Francone; Giulia Cundari; Annalinda Pisano; Giulia d'Amati
Journal:  Cardiovasc Pathol       Date:  2021-10-01       Impact factor: 2.185

6.  Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?

Authors:  Zhaonan Li; Chaoyan Wang; Guangyan Si; Xueliang Zhou; Yahua Li; Jing Li; Dechao Jiao; Xinwei Han
Journal:  BMC Cancer       Date:  2021-04-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.